Page last updated: 2024-10-20

toluene and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

toluene has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thomas, M1
Huang, WS1
Wen, D1
Zhu, X1
Wang, Y1
Metcalf, CA1
Liu, S1
Chen, I1
Romero, J1
Zou, D1
Sundaramoorthi, R1
Li, F1
Qi, J1
Cai, L1
Zhou, T1
Commodore, L1
Xu, Q1
Keats, J1
Wang, F1
Wardwell, S1
Ning, Y1
Snodgrass, JT1
Broudy, MI1
Russian, K1
Iuliucci, J1
Rivera, VM1
Sawyer, TK1
Dalgarno, DC1
Clackson, T1
Shakespeare, WC1

Other Studies

1 other study available for toluene and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant.
    Bioorganic & medicinal chemistry letters, 2011, Jun-15, Volume: 21, Issue:12

    Topics: Administration, Oral; Alkynes; Aniline Compounds; Animals; Cyclization; Disease Models, Animal; Fusi

2011